Alzheimer’s disease alters oligodendrocytic glycolytic and ketolytic gene expression.

Sporadic Alzheimer’s disease (AD) is strongly correlated with impaired brain glucose metabolism, which may affect AD onset and progression. Ketolysis has been suggested as an alternative pathway to fuel the brain.